SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

University of Alabama at Birmingham at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

University of Alabama at Birmingham brings 14 presentations to SNO 2026 in Philadelphia. Its program leans toward experimental therapeutics, including epigenetic drug combinations for diffuse midline glioma and ependymoma. Humanized mouse models and immune-modulating agents for glioblastoma also feature.

OrganizationSNO 2026 Attendance
Universities & institutes
A public research university with a major academic medical center and research programs in cancer and neuro-oncology.
Talk
Thu Nov 12
11:05am–1:50pm
Understanding the Academic Ladder
Terrace Ballroom II Convention Center
Talk
Fri Nov 13
11:48–11:51am
Combined PARP1 and KDM6B Inhibition as a Novel Therapeutic Strategy for H3K27-altered Diffuse Midline Glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-46
Therapeutics
Talk
Fri Nov 13
12:09–12:12pm
Gut microbiota TLR2 signaling associates with immunotherapy responsiveness in glioma-bearing humanized microbiome mice
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-41
Immunology
Talk
Fri Nov 13
12:18–12:21pm
Next-Generation Humanized Mouse Models Recapitulate the Immune Landscape of Glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-29
Therapeutics
Session
Fri Nov 13
5–6pm
A Guide for Blind Spots in Molecular Diagnostics
Terrace Ballroom II & III Convention Center
Pathology
Poster
Fri Nov 13
7:30–9:30pm
Comparative molecular profiling of local and TCGA IDH-wildtype glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-78
Biomarkers
Poster
Fri Nov 13
7:30–9:30pm
EZH2 inhibition reprograms the epigenome and impairs tumor growth in EZHIP-driven PFA ependymoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-12
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Targeting Transcriptional Initiation and Elongation Through Combined BRD4 and CDK9 Inhibition in Diffuse Midline Glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-44
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Tumor-collagen-binding IL-15 superagonist reprograms the immunosuppressive tumor microenvironment in recurrent glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-19
Immunology
Poster
Fri Nov 13
7:30–9:30pm
Automated Labelling of D-Wave Waveforms Using an IONM Foundation Model
Exhibit Hall D & E, Second Floor, Convention Center · Abstract SURG-37
Neurosurgery
Poster
Fri Nov 13
7:30–9:30pm
Intratumoral Hematopoietic Stem and Progenitor Cells Are Locally Reprogrammed to Promote Glioblastoma Progression
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-66
Tumor biology
Talk
Sat Nov 14
11:04–11:09am
Syndecan-2 functions as a regulator of paracrine TGF-β signaling in non–EGFR amplified GBM
118 ABC, First Floor, Convention Center · Abstract CSIG-16
Tumor biology
Talk
Sat Nov 14
11:39–11:42am
Functionally Essential lncRNA CCDC26 as a Novel Therapeutic Target in Diffuse Midline Glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-38
Therapeutics
Talk
Sat Nov 14
11:48–11:51am
FDA-Approved Drug Library Screening Identifies All-Trans Retinoic Acid as a Potent Enhancer of CAR-T Cell Therapy for Brain Tumors
Exhibit Hall D & E, Second Floor, Convention Center · Abstract DDDR-26
Therapeutics

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Alabama at Birmingham

Tell us what you sell and we’ll find the people at University of Alabama at Birmingham most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction